Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
human growth hormone-Fc fusion protein
- Development stage
- Phase 1
- Lead developer
- Changchun Institute of Biological Products
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Administration
- Subcutaneous
01
Overview
Human growth hormone-Fc fusion protein (CCIBPR01005) is a long-acting recombinant human growth hormone (rhGH) fusion protein developed by the Changchun Institute of Biological Products. It consists of human growth hormone fused to the Fc domain of human immunoglobulin G (IgG). By binding to the neonatal Fc receptor (FcRn), the Fc domain protects the fusion protein from lysosomal degradation, thereby significantly extending its circulating half-life and reducing the frequency of subcutaneous injections compared to daily short-acting rhGH. CCIBPR01005 is being developed for the treatment of growth hormone deficiency (GHD) and is currently in Phase I clinical trials.
- Other names
- human growth hormone-Fc fusion proteinhuman growth hormone-Fc fusion protein injection人生长激素-Fc融合蛋白人生长激素-Fc融合蛋白注射液
02
Targets
GHR (Growth hormone receptor)
Beyond the preview
Go deeper on human growth hormone-Fc fusion protein.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on human growth hormone-Fc fusion protein.